Atossa Therapeutics, Inc. (ATOS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Atossa Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.19x | -4.66x | -3.69x | -2.49x | -9.08x | -0.60x |
| P/B Ratio | 1.94x | 1.66x | 1.22x | 0.57x | 1.35x | 0.40x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.53x | 14.99x | 17.61x | 21.23x | 45.18x | 2.73x |
| Quick Ratio | 5.53x | 14.99x | 17.33x | 20.29x | 45.18x | 2.73x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..